Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Single Center Trial of Treatment With Lenalidomide-Melphalan-Dexamethasone in Patients With AL Amyloidosis

NCT00883623 is registered in ClinicalTrials.gov with Heidelberg University as lead sponsor.

NCT NCT00883623
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00883623 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Single Center Trial of Treatment With Lenalidomide-Melphalan-Dexamethasone in Patients With AL Amyloidosis
Lead sponsor
Heidelberg University
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2009
Completion date
February 28, 2013
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary amyloidosis